Publications by authors named "M Algarte Genin"

Background: To evaluate the acceptance and safety of the treatment of newborns with nirsevimab (a long-acting monoclonal antibody designed to prevent respiratory syncytial virus infections) during the first season of implementation.

Methods: A longitudinal, prospective, single-centre cohort study was conducted from September 18th, 2023, to January 23rd, 2024 at Lille University Hospital (Lille, France). All newborns admitted to the hospital's maternity department during the study period and whose parents agreed to participate in the study were included.

View Article and Find Full Text PDF

While pancreatic adenocarcinoma (PA) incidence is increasing, especially in France, the association between pesticides and PA remains unclear. The aims of this study were to assess the spatiotemporal distribution of the incidence of PA in France between 2011 and 2021 and to determine whether pesticide exposure was associated with higher risk of PA. We employed a disease-mapping and ecological regression approach with medicoadministrative data covering 99% of the French population.

View Article and Find Full Text PDF

Context: Bone marrow adiposity (BMAT) alterations in patients with type 2 diabetes mellitus (T2DM) may contribute to adverse bone effects.

Objective: Characterization of BMAT content and composition in patients with well-controlled T2DM.

Methods: This cross-sectional study included 2 groups of postmenopausal women: one with T2DM and the other without.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated how exposure to various air pollutants affects mortality in dialysis patients, using data from 90,373 patients in France between 2012 and 2020.
  • The research found that higher pollution levels were linked to increased all-cause deaths and specifically higher rates of infectious mortality among these patients.
  • Results indicate that air pollution could be a significant factor in the rising deaths related to chronic kidney disease (CKD) globally, with stronger effects observed in women and patients with fewer comorbidities.
View Article and Find Full Text PDF